Jnba Financial Advisors Aeterna Zentaris Inc. Transaction History

Jnba Financial Advisors

  • $980 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022
SELL
$0.33 - $0.42 $30 - $38
-91 Closed
0 $0
Q4 2018

Feb 07, 2019
BUY
$1.3 - $3.87 $118 - $352
91 New
91 $0
Q3 2018

Nov 01, 2018
SELL
$1.6 - $2.03 $145 - $184
-91 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
91
91 $0

About Aeterna Zentaris Inc.

AEZS Quotes by TradingView
  • Ticker AEZS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,855,880
  • Market Cap $19.4M
  • Description
  • Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...
More about AEZS
Track This Portfolio

Track Jnba Financial Advisors Portfolio

Follow Jnba Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email